Detalles de la búsqueda
1.
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
Int J Cancer
; 135(11): 2612-22, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740596
2.
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women.
J Infect Dis
; 207(11): 1753-63, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23242542
3.
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.
Hum Vaccin
; 7(12): 1359-73, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22048172
Resultados
1 -
3
de 3
1
Próxima >
>>